منابع مشابه
Benign Prostatic Hypertrophy (BPH) Treatments
A. Alpha adrenergic blockers (alfuzosin, doxazosin, silodosin, tamsulosin, and terazosin) B. Hormonal manipulation (including finasteride, dutasteride, and dutasteride plus tamsulosin) C. Interstitial laser coagulation of the prostate (ILCP) D. Laser prostatectomy E. Laser based procedures including contact laser ablation of the prostate (CLAP), holmium laser procedures of the prostate (HoLAP, ...
متن کاملModule 3: Benign Prostatic Hypertrophy
1. Identify and name the major anatomic and histologic features of the prostate gland 2. Identify the predominant location in the prostate where BPH develops and describe how this fact relates to the symptoms and signs of BPH 3. Define BPH 4. Describe the distinctive epidemiological features and natural history of BPH 5. List the symptoms and signs of BPH 6. List the important components of the...
متن کاملPalliative Treatment of Benign Prostatic Hypertrophy
In a controlled clinical investigation of benign prostatic hypertrophy, a course of medication containing a mixture of amino acids (Glycine, Alanine and Glutamic Acid) was found to be effective in reducing the size of the prostate and relieving the associated symptoms of discomfort, nocturia, delayed micturition, frequent urination and urgency. As compared with the controls, the results are sta...
متن کاملBladder instability in patients with prostatic hypertrophy.
In 29 patients with urinary obstruction due to prostatic enlargement, medium-fill water cystometry was performed before prostatectomy and again 3 months after. A high incidence of detrusor hyperreflexia was observed pre-operatively, but findings were essentially normal 3 months after resection of the prostate. Possible mechanisms to explain these findings are developed. However, it was clear th...
متن کاملPreparation, Characterization and Stability Study of Dutasteride Loaded Nanoemulsion for Treatment of Benign Prostatic Hypertrophy
Benign prostatic hyperplasia (BPH) is the most common condition in aging men, associated with lower urinary tract symptoms. It is caused due to the augmented levels of the androgen dihydrotestosterone. Dutasteride, a 5α-Reductase inhibitor has been recommended for the treatment of BPH upon oral administration. However, long term oral administration of dutasteride may cause sexual problem in man...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JAMA: The Journal of the American Medical Association
سال: 1899
ISSN: 0098-7484
DOI: 10.1001/jama.1899.92450530015002b